Crossmark

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

Crossref DOI link: https://doi.org/10.1186/s12885-017-3433-z

Published Online: 2017-06-23

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schrijnders, Dennis https://orcid.org/0000-0001-8952-6989
de Bock, Geertruida H.

Houweling, Sebastiaan T.

van Hateren, Kornelis J. J.

Groenier, Klaas H.

Johnson, Jeffrey A.

Bilo, Henk J. G.

Kleefstra, Nanne

Landman, Gijs W. D.
Funding

Funding for this research was provided by:

ZonMw (836041017)